Evidence map›Paper›PMID 15825827›Full record

ArticleLipids2005

Molecular evidence that the rate-limiting step for the biosynthesis of arachidonic acid in Mortierella alpina is at the level of an elongase.

Seiki Takeno, Eiji Sakuradani, Shoichi Murata, Misa Inohara-Ochiai, Hiroshi Kawashima, Toshihiko Ashikari, Sakayu Shimizu

Abstract read
PubMed Publisher
In one paragraph

Article in Lipids, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 44 citations in OpenAlex.

  1. Novel Approaches toACS omega · 2024
    Article
  2. Article
  3. Article
  4. Arachidonic acid production by the oleaginous fungusJournal of advanced research · 2018
    Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Seiki TakenoLaboratory of Fermentation Physiology and Applied Microbiology, Graduate School of Agriculture, Kyoto University, Kyoto 606-8502, Japan.
Eiji Sakuradani
Shoichi Murata
Misa Inohara-Ochiai
Hiroshi Kawashima
Toshihiko Ashikari
Sakayu Shimizu
Kyoto University · JPSuntory (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The oil-producing fungus Mortierella alpina 1S-4 is an industrial strain for arachidonic acid (AA) production. To determine its physiological properties and to clarify the biosynthetic pathways for PUFA, heterologous and homologous gene expression systems were established in this fungus. The first trial was performed with an enhanced green fluorescent protein gene to assess the transformation efficiency for heterologous gene expression. As a result, strong fluorescence was observed in the spores of the obtained transformant, suggesting that the foreign gene was inherited by the spores. The next trial was performed with a homologous PUFA elongase (GLELOp) gene, this enzyme having been reported to catalyze the elongation of GLA (18:3n-6) to dihomo-gamma-linolenic acid (20:3n-6), and to be the rate-limiting step of AA production. The FA composition of the transformant was different from that of the host strain: The GLA content was decreased whereas that of AA was increased. These data support the hypothesis that the GLELOp enzyme plays an important role in PUFA synthesis, and may indicate how to control PUFA biosynthesis.

Indexed as

AcetyltransferasesArachidonic AcidFatty Acid ElongasesFatty AcidsFatty Acids, UnsaturatedFungal Proteinsgamma-Linolenic AcidKineticsMortierellaAcetyltransferasesArachidonic AcidFatty Acid ElongasesFatty AcidsFatty Acids, UnsaturatedFungal Proteinsgamma-Linolenic Acid

Identifiers

PMID15825827
OpenAlexW2060605266

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.